Australia, Aug. 1 -- Glaxo Group Ltd., owns the trademark (2628782) for 'LEYTOMIC' till Jan. 2, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical and medicinal preparations and substances; vaccines.]
Type of Mark: Word
Date of Acceptance: March 12
Registration Advertised: July 31
For further details contact GSK Legal Brand Protection.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2628782.
Disclaimer: Curated by HT Syndication.
